A synthetic assortment model shows why SKU rationalization depends on substitution, complements, stockouts, shelf space, and basket economics.

A synthetic returns-policy model separates conversion confidence from return abuse, reverse logistics cost, refund speed, and customer backlash.

A synthetic retail media model separates attributed sales from incremental sales when organic intent, audience overlap, offline linkage, and control quality matter.

A synthetic retail promotion model separates sales lift from contribution profit when discounts, inventory, substitutions, returns, and fulfillment costs move together.

A synthetic biosimilar savings model shows why availability alone may not lower spending when substitution, formulary placement, rebates, inventory, prescriber trust, and patient cost share are unresolved.

A synthetic influence-style infusion model compares site-of-care decisions across safety, treatment completion, avoidable cost, patient burden, and payer policy.

A synthetic plan-year model shows how approval timing, eligible population, price tier, stop-loss readiness, rebates, provider capacity, and access friction can combine into budget shock.

A synthetic Marketplace integrity model separates improper enrollment risk from consumer confusion, subsidy exposure, notices, agent oversight, and coverage disruption.

Anti-fraud actions can protect public dollars and still create access pressure when review capacity, payment holds, provider supply, and beneficiary complexity collide.

A synthetic credentialing model shows why a clinician can be clinically acceptable and still miss a start date because approvals, documents, EHR access, orientation, and payer enrollment move on different clocks.